Skip to main content

Grafa News and Videos — Page 1035

Grafa Headlines

Latest

Grafa

Context Therapeutics reports positive interim Phase 1a data for ovarian cancer therapy

Context Therapeutics (NASDAQ:CNTX) revealed encouraging preliminary clinical data from its Phase 1a trial evaluating CTIM-76, an investigational bispecific T cell engager designed to target claudin 6 (CLDN6) and engage CD3 T cells.

Read more: Context Therapeutics reports positive interim Phase 1a data for ovarian cancer therapy
Grafa

Johnson & Johnson invests over $1 billion to expand Vision operations in Jacksonville

Johnson & Johnson (NYSE:JNJ) has committed more than $1 billion to expand and modernize its Vision care operations in Jacksonville, Florida, targeting increased capacity for its market-leading ACUVUE®-brand contact lenses.

Read more: Johnson & Johnson invests over $1 billion to expand Vision operations in Jacksonville

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift